| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.048 | 0.4 |